Bramble Energy, the world’s most scalable hydrogen fuel cell company has raised a £5m Series A round. BGF led the round and was joined by existing investors inc [...]
About Lucy TuffinThis author has not yet filled in any details.
So far Lucy Tuffin has created 93 blog entries.
UCL Technology Fund (UCLTF), managed by AlbionVC in collaboration with UCL Business (UCLB) (the university’s commercialisation company and part of UCL Innovatio [...]
Humanloop, a game changing UCL spinout, has attracted investment from UCL’s Technology Fund (UCLTF). Based on the world-leading research of two notable academic [...]
UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firmLucy Tuffin2020-07-21T09:02:20+01:00
UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technolog [...]
Research England has awarded two grants, totalling £1.5 million, to support two programmes working to dramatically increase the economic value and social impact [...]
Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, announced the closing of a $120 million extended [...]
LONDON – 25th June 2020 – UCL Business (UCLB) has won the Knowledge Exchange External Initiative of the Year in this year’s KE Awards organised by Praxis-Auril. [...]
UCL Technology Fund (UCLTF), managed by AlbionVC in collaboration with UCL Business (UCLB), has funded UCL’s Cancer Institute in repurposing a sophisticated an [...]
Achilles Therapeutics doses first patient in Phase I/II Study in recurrent or metastatic malignant melanoma with first TIL therapy to specifically target clonal neoantigensLucy Tuffin2020-06-02T12:50:53+01:00
Achilles Therapeutics was formed in October 2016 by Syncona Ltd and Cancer Research Technology, with the support of UCLB and the Francis Crick Institute. Steven [...]
Orchard Therapeutics Announces First Patient Dosed with OTL-201 Gene Therapy in Proof-of-Concept Clinical Trial for Sanfilippo Syndrome (MPS-IIIA)Lucy Tuffin2020-04-28T12:38:15+01:00
BOSTON and LONDON, April 27, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the first patient [...]